Robin Lovell-Badge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robin Lovell-Badge has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Ander Matheu
Cellular Oncology Group, Biogipuzkoa Health Research Institute, Spain
2 shared publications Christophe Galichet
Division of Stem Cell Biology and Developmental Genetics, MRC National Institute for Medical Research, London NW7 1AA, United Kingdom
2 shared publications- Manuel Serrano
Altos Labs, Cambridge, UK
2 shared publications - Ryohei Sekido
Division of Stem Cell Biology and Developmental Genetics, MRC National Institute for Medical Research, London NW7 AA, UK
2 shared publications Abdul K. Sesay
Division of Stem Cell Biology and Developmental Genetics, MRC National Institute for Medical Research, London NW7 1AA, United Kingdom
1 shared publicationAdolfo López de Munain
1 shared publication
Latest Publications
- Open Access
- 20 May 2015
- Published by Wiley in Aging Cell
- Vol. 14 (4) , 710-714
Increased gene dosage ofInk4/Arfandp53delays age-associated central nervous system functional decline
The impairment of the activity of the brain is a major feature of aging, which coincides with a decrease in the function of neural stem cells. We have previously shown that an extra copy of regulated Ink4/Arf and p53 activity, in s‐Ink4/Arf/p53 mice, elongates lifespan and delays aging. In this work, we examined the physiology of the s‐Ink4/Arf/p53 brain with aging, focusing on the neural stem cell (NSC) population. We show that cells derived from old s‐Ink4/Arf/p53 mice display enhanced neurosphere formation and self‐renewal activity compared with wt controls. This correlates with augmented expression of Sox2, Sox9, Glast, Ascl1, and Ars2 NSC markers in the subventricular zone (SVZ) and in the subgranular zone of the dentate gyrus (DG) niches. Furthermore, aged s‐Ink4/Arf/p53 mice express higher levels of Doublecortin and PSA‐NCAM (neuroblasts) and NeuN (neurons) in the olfactory bulbs (OB) and DG, indicating increased neurogenesis in vivo. Finally, aged s‐Ink4/Arf/p53 mice present enhanced behavioral and neuromuscular coordination activity. Together, these findings demonstrate that increased but regulated Ink4/Arf and p53 activity ameliorates age‐related deterioration of the central nervous system activity required to maintain the stem cell pool, providing a mechanism not only for the extended lifespan but also for the health span of these mice.
- 20 May 2015
- Published by Wiley in Aging Cell
- Vol. 14 (4) , 710-714
Open AccessIncreased gene dosage ofInk4/Arfandp53delays age-associated central nervous system functional decline
The impairment of the activity of the brain is a major feature of aging, which coincides with a decrease in the function of neural stem cells. We have previously shown that an extra copy of regulated Ink4/Arf and p53 activity, in s‐Ink4/Arf/p53 mice, elongates lifespan and delays aging. In this work, we examined the physiology of the s‐Ink4/Arf/p53 brain with aging, focusing on the neural stem cell (NSC) population. We show that cells derived from old s‐Ink4/Arf/p53 mice display enhanced neurosphere formation and self‐renewal activity compared with wt controls. This correlates with augmented expression of Sox2, Sox9, Glast, Ascl1, and Ars2 NSC markers in the subventricular zone (SVZ) and in the subgranular zone of the dentate gyrus (DG) niches. Furthermore, aged s‐Ink4/Arf/p53 mice express higher levels of Doublecortin and PSA‐NCAM (neuroblasts) and NeuN (neurons) in the olfactory bulbs (OB) and DG, indicating increased neurogenesis in vivo. Finally, aged s‐Ink4/Arf/p53 mice present enhanced behavioral and neuromuscular coordination activity. Together, these findings demonstrate that increased but regulated Ink4/Arf and p53 activity ameliorates age‐related deterioration of the central nervous system activity required to maintain the stem cell pool, providing a mechanism not only for the extended lifespan but also for the health span of these mice.
- Open Access
- 5 September 2012
- Published by S. Karger AG in Sexual Development
- Vol. 7 (1-3) , 21-32
Genetic Control of Testis Development
Sex determination refers to the decision of the bipotential early gonads to develop as either testes or ovaries during embryogenesis. In mammals, a single genetic trigger involved in this pivotal decision has been identified on the Y chromosome: the testis-determining gene SRY/Sry. During embryogenesis, SRY triggers the differentiation of Sertoli cells from the supporting cell precursor lineage which would otherwise give granulosa cells in ovaries. Several testis-specific events occur after SRY expression and the onset of Sertoli cell differentiation, notably Leydig cell differentiation, testis cord formation, and development of testis-specific vasculature. Although a number of genes involved in these events have been identified, how they relate to Sry action is poorly understood. Furthermore, even at the adult stage, some of these genes retain a key role in maintaining the testicular fate because conditional ablation of the genes leads to adult testis dysgenesis or transdifferentiation into an ovary. This sheds light on mammalian sex-reprogramming, despite the prevailing dogma that postnatal sex change does not occur in mammals. In this review, we summarize our current understanding of genetic pathways of testis determination and differentiation in mammals, particularly in the mouse and the human.
- 5 September 2012
- Published by S. Karger AG in Sexual Development
- Vol. 7 (1-3) , 21-32
Open AccessGenetic Control of Testis Development
Sex determination refers to the decision of the bipotential early gonads to develop as either testes or ovaries during embryogenesis. In mammals, a single genetic trigger involved in this pivotal decision has been identified on the Y chromosome: the testis-determining gene SRY/Sry. During embryogenesis, SRY triggers the differentiation of Sertoli cells from the supporting cell precursor lineage which would otherwise give granulosa cells in ovaries. Several testis-specific events occur after SRY expression and the onset of Sertoli cell differentiation, notably Leydig cell differentiation, testis cord formation, and development of testis-specific vasculature. Although a number of genes involved in these events have been identified, how they relate to Sry action is poorly understood. Furthermore, even at the adult stage, some of these genes retain a key role in maintaining the testicular fate because conditional ablation of the genes leads to adult testis dysgenesis or transdifferentiation into an ovary. This sheds light on mammalian sex-reprogramming, despite the prevailing dogma that postnatal sex change does not occur in mammals. In this review, we summarize our current understanding of genetic pathways of testis determination and differentiation in mammals, particularly in the mouse and the human.
- 1 March 2012
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 72 (5) , 1301-1315
Oncogenicity of the Developmental Transcription Factor Sox9
SOX9 [sex-determining region Y (SRY)-box 9 protein], a high mobility group box transcription factor, plays critical roles during embryogenesis and its activity is required for development, differentiation, and lineage commitment in various tissues including the intestinal epithelium. Here, we present functional and clinical data of a broadly important role for SOX9 in tumorigenesis. SOX9 was overexpressed in a wide range of human cancers, where its expression correlated with malignant character and progression. Gain of SOX9 copy number is detected in some primary colorectal cancers. SOX9 exhibited several pro-oncogenic properties, including the ability to promote proliferation, inhibit senescence, and collaborate with other oncogenes in neoplastic transformation. In primary mouse embryo fibroblasts and colorectal cancer cells, SOX9 expression facilitated tumor growth and progression whereas its inactivation reduced tumorigenicity. Mechanistically, we have found that Sox9 directly binds and activates the promoter of the polycomb Bmi1, whose upregulation represses the tumor suppressor Ink4a/Arf locus. In agreement with this, human colorectal cancers showed a positive correlation between expression levels of SOX9 and BMI1 and a negative correlation between SOX9 and ARF in clinical samples. Taken together, our findings provide direct mechanistic evidence of the involvement of SOX9 in neoplastic pathobiology, particularly, in colorectal cancer. Cancer Res; 72(5); 1301–15. ©2012 AACR.
- 1 March 2012
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 72 (5) , 1301-1315
Oncogenicity of the Developmental Transcription Factor Sox9
SOX9 [sex-determining region Y (SRY)-box 9 protein], a high mobility group box transcription factor, plays critical roles during embryogenesis and its activity is required for development, differentiation, and lineage commitment in various tissues including the intestinal epithelium. Here, we present functional and clinical data of a broadly important role for SOX9 in tumorigenesis. SOX9 was overexpressed in a wide range of human cancers, where its expression correlated with malignant character and progression. Gain of SOX9 copy number is detected in some primary colorectal cancers. SOX9 exhibited several pro-oncogenic properties, including the ability to promote proliferation, inhibit senescence, and collaborate with other oncogenes in neoplastic transformation. In primary mouse embryo fibroblasts and colorectal cancer cells, SOX9 expression facilitated tumor growth and progression whereas its inactivation reduced tumorigenicity. Mechanistically, we have found that Sox9 directly binds and activates the promoter of the polycomb Bmi1, whose upregulation represses the tumor suppressor Ink4a/Arf locus. In agreement with this, human colorectal cancers showed a positive correlation between expression levels of SOX9 and BMI1 and a negative correlation between SOX9 and ARF in clinical samples. Taken together, our findings provide direct mechanistic evidence of the involvement of SOX9 in neoplastic pathobiology, particularly, in colorectal cancer. Cancer Res; 72(5); 1301–15. ©2012 AACR.
- 9 January 2012
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (4) , 1317-1322
Betacellulin promotes cell proliferation in the neural stem cell niche and stimulates neurogenesis
Neural stem cells (NSCs) reside in specialized niches in the adult mammalian brain, including the subventricular zone and the dentate gyrus, which act to control NSC behavior. Among other cell types within these niches, NSCs are found in close proximity to blood vessels. We carried out an analysis of the interaction between endothelial cells and NSCs, and show that betacellulin (BTC), a member of the EGF family and one of several signaling molecules made by the former, induces NSC proliferation and prevents spontaneous differentiation in culture. When infused into the lateral ventricle, BTC induces expansion of NSCs and neuroblasts, and promotes neurogenesis in the olfactory bulb and dentate gyrus, whereas specific blocking antibodies reduce the number of stem/progenitor cells. BTC-null mice are less able to regenerate neuroblast numbers compared with WT littermates following depletion of proliferating cells using cytosine-β- d -arabinofuranoside. BTC acts via both the EGF receptor, located on NSCs, and ErbB4, located on neuroblasts, with the latter explaining why its effects are distinct from those of EGF itself. Our results suggest that BTC could be a good candidate to aid regenerative therapies.
- 9 January 2012
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (4) , 1317-1322
Betacellulin promotes cell proliferation in the neural stem cell niche and stimulates neurogenesis
Neural stem cells (NSCs) reside in specialized niches in the adult mammalian brain, including the subventricular zone and the dentate gyrus, which act to control NSC behavior. Among other cell types within these niches, NSCs are found in close proximity to blood vessels. We carried out an analysis of the interaction between endothelial cells and NSCs, and show that betacellulin (BTC), a member of the EGF family and one of several signaling molecules made by the former, induces NSC proliferation and prevents spontaneous differentiation in culture. When infused into the lateral ventricle, BTC induces expansion of NSCs and neuroblasts, and promotes neurogenesis in the olfactory bulb and dentate gyrus, whereas specific blocking antibodies reduce the number of stem/progenitor cells. BTC-null mice are less able to regenerate neuroblast numbers compared with WT littermates following depletion of proliferating cells using cytosine-β- d -arabinofuranoside. BTC acts via both the EGF receptor, located on NSCs, and ErbB4, located on neuroblasts, with the latter explaining why its effects are distinct from those of EGF itself. Our results suggest that BTC could be a good candidate to aid regenerative therapies.
- Open Access
- 31 January 2011
- Published by Wiley in The FEBS Journal
- Vol. 278 (7) , 1002-1009
Sex determination and the control of Sox9 expression in mammals
In mouse sex determination, the presence or absence of Sertoli cells in the developing gonad is essential for the decision to form either a testis or an ovary. The transcription factor SOX9 has emerged as the master regulator of Sertoli cell differentiation during testis development and thus the crucial gene to determine sex. It is the target of two sets of regulatory controls, one positive and one negative, where one set tries to gain dominance over the other in the early gonad and then to establish and maintain the activity or silence of Sox9 throughout life. The data reveal the importance of the positive regulatory loops to reinforce initial decisions, whereas the maintenance of the gonadal phenotype appears to rely on the active repression of the opposite pathway.
- 31 January 2011
- Published by Wiley in The FEBS Journal
- Vol. 278 (7) , 1002-1009
Open AccessSex determination and the control of Sox9 expression in mammals
In mouse sex determination, the presence or absence of Sertoli cells in the developing gonad is essential for the decision to form either a testis or an ovary. The transcription factor SOX9 has emerged as the master regulator of Sertoli cell differentiation during testis development and thus the crucial gene to determine sex. It is the target of two sets of regulatory controls, one positive and one negative, where one set tries to gain dominance over the other in the early gonad and then to establish and maintain the activity or silence of Sox9 throughout life. The data reveal the importance of the positive regulatory loops to reinforce initial decisions, whereas the maintenance of the gonadal phenotype appears to rely on the active repression of the opposite pathway.
- 1 March 2010
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 42 (3) , 378-380
The early history of the Sox genes
- 1 March 2010
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 42 (3) , 378-380
The early history of the Sox genes
- 31 August 2009
- Published by Elsevier in Mechanisms of Development
- Vol. 126, S160-160
09-P033 Expression of SOX3 in the urogenital ridge is associated with XX male sex reversal in mice
- 31 August 2009
- Published by Elsevier in Mechanisms of Development
- Vol. 126, S160-160
09-P033 Expression of SOX3 in the urogenital ridge is associated with XX male sex reversal in mice
- 31 August 2009
- Published by Elsevier in Mechanisms of Development
- Vol. 126, S142-S143
07-P021 Sox3 deletion in the central nervous system affects pituitary endocrine cell size
- 31 August 2009
- Published by Elsevier in Mechanisms of Development
- Vol. 126, S142-S143
07-P021 Sox3 deletion in the central nervous system affects pituitary endocrine cell size
- Open Access
- 1 January 2009
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 3
Direct effects of X and Y-linked genes on sex-specific differences in the brain and behaviour
In mammalian sex determination, the Y-linked gene Sry acts within the early gonad as a switch to trigger high expression of Sox9 in cells of the supporting cell lineage. SOX9 then acts on many target genes required for Sertoli cell differentiation and function. These include signalling molecules such as AMH, which eliminates the anlagen of the female reproductive tract in male embryos, as well as other molecules that direct the differentiation of other cell types along the male pathway, including steroidogenic cell precursors, which differentiate into Leydig cells. The latter synthesise testosterone (T), which masculinises the rest of the embryo either directly or after to conversion to dihydrotestosterone (DHT) or estrogen (E) at sites of action, including the brain. Until fairly recently many believed that all differences in the brain and behaviour were due to the activity of T or high levels of E during late fetal or early postnatal development. However, there are many genes on the X and a few on the Y chromosome that could exert direct effects, either independently of steroid hormone action or in conjunction with it. Indeed recent work has suggested that this is indeed the case. Sry itself is expressed in the brain, as are other Y-linked genes. And despite the process of X chromosome inactivation, which equalises X-linked gene dosage between males and females, many X-linked genes can have an effect either because they escape inactivation or because they are subject to parental genomic imprinting (where alleles behave differently according to whether they are maternally or paternally inherited). I will review the current status of research in this area as well as describe our own contribution.
- 1 January 2009
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 3
Open AccessDirect effects of X and Y-linked genes on sex-specific differences in the brain and behaviour
In mammalian sex determination, the Y-linked gene Sry acts within the early gonad as a switch to trigger high expression of Sox9 in cells of the supporting cell lineage. SOX9 then acts on many target genes required for Sertoli cell differentiation and function. These include signalling molecules such as AMH, which eliminates the anlagen of the female reproductive tract in male embryos, as well as other molecules that direct the differentiation of other cell types along the male pathway, including steroidogenic cell precursors, which differentiate into Leydig cells. The latter synthesise testosterone (T), which masculinises the rest of the embryo either directly or after to conversion to dihydrotestosterone (DHT) or estrogen (E) at sites of action, including the brain. Until fairly recently many believed that all differences in the brain and behaviour were due to the activity of T or high levels of E during late fetal or early postnatal development. However, there are many genes on the X and a few on the Y chromosome that could exert direct effects, either independently of steroid hormone action or in conjunction with it. Indeed recent work has suggested that this is indeed the case. Sry itself is expressed in the brain, as are other Y-linked genes. And despite the process of X chromosome inactivation, which equalises X-linked gene dosage between males and females, many X-linked genes can have an effect either because they escape inactivation or because they are subject to parental genomic imprinting (where alleles behave differently according to whether they are maternally or paternally inherited). I will review the current status of research in this area as well as describe our own contribution.
- 1 December 2008
- Published by Springer Nature in Nature Reviews Molecular Cell Biology
- Vol. 9 (12) , 998-1003
The regulation of human embryo and stem-cell research in the United Kingdom
The 1990 Human Fertilisation and Embryology (HFE) Act and its amendments regulate the derivation of human embryonic stem cells in the United Kingdom. A new bill, which has just passed through Parliament, will have important consequences for research in embryos and stem cells. In the United Kingdom, the derivation of human embryonic stem (ES) cells falls under the 1990 Human Fertilisation and Embryology (HFE) Act and subsequent amendments that were adopted in 2001. These laws do not regulate research with ES cells, which follows specific national guidelines. Owing to rapid progress in science and to changes in legal and public opinion, the current British Government proposed further radical amendments in a new HFE Bill. These will have important consequences for research and clinical practice that involve both embryos and stem cells.
- 1 December 2008
- Published by Springer Nature in Nature Reviews Molecular Cell Biology
- Vol. 9 (12) , 998-1003
The regulation of human embryo and stem-cell research in the United Kingdom
The 1990 Human Fertilisation and Embryology (HFE) Act and its amendments regulate the derivation of human embryonic stem cells in the United Kingdom. A new bill, which has just passed through Parliament, will have important consequences for research in embryos and stem cells. In the United Kingdom, the derivation of human embryonic stem (ES) cells falls under the 1990 Human Fertilisation and Embryology (HFE) Act and subsequent amendments that were adopted in 2001. These laws do not regulate research with ES cells, which follows specific national guidelines. Owing to rapid progress in science and to changes in legal and public opinion, the current British Government proposed further radical amendments in a new HFE Bill. These will have important consequences for research and clinical practice that involve both embryos and stem cells.